Home
Browse All Titles
Sign In
Browse All Titles
Physicians' Cancer Chemotherapy Drug Manual
About
Table of Contents
Main Index
Trade Names
Classification Index
Category Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
▶
View All
Bactrim DS
Leukemia
Lymphoma
Balversa
Bavencio
BAY 73-4506
BCNU
BEACOPP
escalated
Lymphoma
belantamab mafadotin
belinostat
Belinostat
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Lymphoma
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
bendamustine
Bendamustine
Lymphoma
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Leukemia
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Waldenström's Macroglobulinemia
BEP
Ovarian Cancer (Epithelial)
Testicular Cancer
Ovarian Cancer (Germ Cell)
bevacizumab
Bevacizumab
Breast Cancer
Cervical Cancer
Lung Cancer
Prostate Cancer
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Brain Cancer
Cancer of Unknown Primary
Colorectal Cancer
Ovarian Cancer (Epithelial)
Renal Cell Cancer
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Bexxar
BGB-3111
BIC
bicalutamide
Prostate Cancer
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
Bicalutamide
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
biliary tract cancer
binimetinib
Colorectal Cancer
Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Binimetinib
Malignant Melanoma
Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
biosimilar to rituximab
Rituximab-pvvr
Rituximab-abbs
basal cell cancer
BAY 43-9006
bb121
BDR
Beleodaq
Besponsa
bexarotene
bezultifan
BGJ398
biosimilar to trastuzumab
BIP
bladder cancer
Refresh
first
prev
1
2
30
select
next
last
Displaying items 1 - 30 of 58